首页> 外文期刊>International archives of allergy and immunology >A nasally applied cellulose powder in seasonal allergic rhinitis in adults with grass pollen allergy: A double-blind, randomized, placebo-controlled, parallel-group study
【24h】

A nasally applied cellulose powder in seasonal allergic rhinitis in adults with grass pollen allergy: A double-blind, randomized, placebo-controlled, parallel-group study

机译:经鼻应用的纤维素粉治疗对花粉过敏的成人季节性过敏性鼻炎:双盲,随机,安慰剂对照,平行组研究

获取原文
获取原文并翻译 | 示例
       

摘要

Background: A nasally applied cellulose powder is increasingly used in many countries as a remedy for allergic rhinitis. In 2009, a 4-week study in birch pollen-allergic children showed a reduction in nasal symptoms. The best effect occurred on days with lower pollen counts. The present study in grass pollen-allergic adults used the same basic design. Methods: In May 2013, a double-blind, placebo-controlled study was conducted in 108 patients with allergic rhinitis due to grass pollen (18-40 years of age). SMS on mobile phones were used as reminders of treatment and reporting of symptom scores. Results: We found significant reductions in severity scores for sneezing, runny nose, stuffy nose and symptoms from eyes and lower airways, both separately and together (all p < 0.001). Reflective opinion of effect and guess on treatment at follow-up visits (both p < 0.001) confirmed a high efficacy. No clinically significant adverse effects were reported. Conclusions: The product provided significant protection against all seasonal allergic rhinitis symptoms from both upper and lower airways during the grass pollen season in an adult population. The magnitude and scope of efficacy support the use of the product as an early choice in the treatment of allergic rhinitis.
机译:背景:在许多国家,鼻腔施用的纤维素粉末越来越多地用作过敏性鼻炎的治疗方法。 2009年,对桦树花粉过敏儿童进行的为期4周的研究显示,鼻部症状有所减轻。最佳效果发生在花粉数较低的日子。本研究对花粉过敏的成年人使用相同的基本设计。方法:2013年5月,对108名因花粉引起的过敏性鼻炎的患者(18至40岁)进行了一项双盲,安慰剂对照研究。手机上的短信被用来提醒治疗和报告症状评分。结果:我们发现打喷嚏,流鼻涕,鼻塞以及眼睛和下呼吸道症状的严重性评分分别降低或降低了很多(均为p <0.001)。在随访中对治疗的效果和猜测的反思性意见(均p <0.001)证实了高疗效。没有临床上显着的不良反应报道。结论:该产品在成年人群的花粉季节对上呼吸道和下呼吸道的所有季节性变应性鼻炎症状提供了有效的保护。功效的大小和范围支持该产品在过敏性鼻炎治疗中的早期选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号